Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism Mitochondrial complex I: NADH:ubiquinone oxidoreductase subunits inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Tularemia | Preclinical | United States | 07 Dec 2025 |





